查看購物車
  • Simplified Chinese
  • English
  • Japanese
亞太蛋白質體學市場（按產品、應用和國家分類）分析與預測（2024 年至 2034 年）
市場調查報告書
商品編碼
1743358

亞太蛋白質體學市場（按產品、應用和國家分類）分析與預測（2024 年至 2034 年）

Asia-Pacific Proteomics Market: Focus on Offerings, Application, and Country - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 81 Pages | 商品交期: 1-5個工作天內

價格

亞太蛋白質體學市場規模預計將從 2024 年的 69.5 億美元增至 2034 年的 257.8 億美元，2024-2034 年預測期間的複合年成長率為 14.01%。

亞太地區的蛋白質體學產業正在迅速擴張，這得益於提供高度精確的蛋白質分析和質譜分析的下一代定序技術的發展，部分原因是人們對個人化醫療的日益重視，這導致了新生物標記的發現和疾病分析工具的改進。

透過不斷擴大官民合作關係以及醫院、生物技術公司和學術機構之間的合作，新的蛋白質組學應用正在更快地發展，亞太地區各國政府也正在透過國家資金籌措計畫鼓勵研發和創新。此外，該地區人口老化加劇和慢性病盛行率上升，迫切需要更先進的診斷設備和早期檢測技術。

主要市場統計數據
預測期 2024-2034
2024年評估 69.5億美元
2034年的預測 257.8億美元
複合年成長率 14.01%

隨著亞太地區繼續投資生命科學並加強其臨床研究基礎設施，蛋白質體學正在成為推動全部區域精準醫療和醫療保健創新的重要支柱。

蛋白質體學是亞太地區生命科學生物技術領域潛力市場。隨著質譜、次世代定序(NGS) 和生物資訊學等分析技術的發展，蛋白質體學解決方案在全部區域的研究、診斷和藥物開發應用中的應用日益廣泛。醫療保健支出的增加、慢性病發病率的上升以及個人化治療的趨勢，推動了臨床和轉化研究對更深入的蛋白質水平洞察的需求。

中國、印度、日本、韓國和新加坡等國政府正透過國家研發計畫、基礎建設和財政項目推動蛋白質體學的發展。生技公司、學術機構和醫療保健機構之間的官民合作關係也推動著蛋白質體學技術和平台的創新。此外，人工智慧和機器學習在蛋白質數據處理中的日益融合，正在提高準確性、速度和可擴展性。

儘管取得了這些進展，但諸如技術成本高昂、合格人才短缺以及欠低度開發國家難以獲得尖端研究設施等挑戰仍然存在。然而，隨著精準醫療領域的興趣和資金持續成長，亞太地區蛋白質組學市場預計將穩步成長，並在全部區域診斷和治療方法的變革中發揮關鍵作用。

市場區隔

細分 1：按產品

  • 產品
  • 服務

細分2：按應用

  • 藥物研發
  • 臨床診斷
  • 其他

細分3：按地區

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他

亞太蛋白質體學市場趨勢、促進因素與挑戰

趨勢

  • 質譜和次世代定序等高通量技術的採用日益增多
  • 個人化醫療和精準醫療日益受到關注
  • 拓展蛋白質體學在疾病診斷、藥物開發和生物標記發現的應用
  • 擴大產學合作與公私合作研究夥伴關係
  • 人工智慧與生物資訊學在蛋白質體學數據分析中的整合

驅動程式

  • 政府透過國家研發計劃和醫療現代化計劃提供支持
  • 生物技術和製藥公司加大對蛋白質體學研究的投資
  • 慢性病增加和人口老化推動早期檢測需求
  • 亞太新興國家醫療支出增加、基礎建設改善
  • 該地區臨床試驗和轉化研究快速成長

任務

  • 蛋白質體學儀器和數據分析平台高成本
  • 中低收入國家取得先進技術的機會有限
  • 缺乏熟練的專業人員和生物資訊學專家
  • 複雜的數據解釋和標準化問題
  • 關於患者數據使用和生物標記檢驗的監管和倫理問題

產品/創新策略：亞太蛋白質體學市場已根據產品、應用、國家等不同類別進行了廣泛細分。這有助於讀者清楚概況哪個細分市場佔有最大佔有率以及哪個細分市場在未來幾年可能會成長。

競爭策略：亞太蛋白質體學市場擁有許多擁有豐富產品和服務組合的現有企業。本研究分析和概述的亞太蛋白質體學市場主要企業包括提供蛋白質體學產品和服務的現有企業。

本報告研究了亞太蛋白質組學市場，並概述了市場、產品、應用和國家趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章 市場

  • 市場展望
  • 主要發現
  • 亞太蛋白質體學市場概況
  • 產業展望
  • 趨勢：現況與未來影響評估
  • 專利分析
  • 法律規範
  • 產品基準
  • 市場動態概覽

2. 蛋白質體學市場（按地區分類），百萬美元，2022 年至 2034 年

  • 區域摘要
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 亞太蛋白質體學市場（按應用）
    • 亞太蛋白質體學市場（按產品提供）
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國
    • 其他

第3章 市場競爭基準化分析與公司概況

  • 蛋白質體學市場：競爭格局
    • 企業策略 2022 年 1 月 - 2024 年 12 月
  • 公司簡介
    • Takara Bio Inc.

第4章調查方法

Product Code: BHP2992SS

Introduction to Asia-Pacific Proteomics Market

The Asia-Pacific proteomics market is projected to reach $25.78 billion by 2034 from $6.95 billion in 2024, growing at a CAGR of 14.01% during the forecast period 2024-2034. The Asia-Pacific (APAC) proteomics industry is expanding rapidly due to developments in next-generation sequencing technologies that provide high-precision protein analysis and mass spectrometry. The growing emphasis on individualised healthcare, together with increased attempts to find new biomarkers and improve disease profiling tools, is another factor contributing to this trend.

New proteomic applications are being developed more quickly thanks to expanding public-private partnerships and cooperation between hospitals, biotech companies, and academic institutions, while governments around APAC are promoting research and innovation through national financing programs. Furthermore, there is an urgent need for better diagnostic instruments and early detection techniques due to the region's growing senior population and the increase in the prevalence of chronic illnesses.

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$6.95 Billion
2034 Forecast$25.78 Billion
CAGR14.01%

Proteomics is emerging as a key pillar in promoting precision medicine and healthcare innovation across the region as APAC keeps investing in life sciences and fortifying its clinical research infrastructure.

Market Introduction

Proteomics is a fast developing, high-potential market in the life sciences and biotechnology sector in Asia-Pacific (APAC). Proteomic solutions are increasingly being used in research, diagnostics, and drug development applications throughout the region, driven by developments in analytical technologies including mass spectrometry, next-generation sequencing (NGS), and bioinformatics. The need for more in-depth protein-level insights in clinical and translational research is being fuelled by rising healthcare expenditures, the incidence of chronic diseases, and the trend towards personalised therapy.

Governments in China, India, Japan, South Korea, and Singapore promote proteomics through national R&D initiatives, infrastructure development, and financial programs. Innovation in proteomics techniques and platforms is also being accelerated by public-private partnerships among biotech companies, academic institutions, and healthcare providers. Furthermore, accuracy, speed, and scalability are being improved by the increasing integration of AI and machine learning in protein data processing.

Notwithstanding these developments, issues including exorbitant technological costs, a shortage of qualified personnel, and restricted access to cutting-edge research facilities in underdeveloped countries continue to exist. But as interest in and funding for precision healthcare continue to rise, the APAC proteomics market is expected to grow steadily and play a significant part in changing diagnostic and treatment approaches throughout the area.

Market Segmentation:

Segmentation 1: by Offering

  • Product
  • Service

Segmentation 2: by Application

  • Drug Discovery
  • Clinical Diagnostics
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest-of-Asia-Pacific

APAC Proteomics Market Trends, Drivers and Challenges

Trends

  • Increasing adoption of high-throughput technologies like mass spectrometry and next-generation sequencing
  • Rising focus on personalized medicine and precision healthcare
  • Expansion of proteomic applications in disease diagnostics, drug development, and biomarker discovery
  • Growth in academic-industry collaborations and public-private research partnerships
  • Integration of AI and bioinformatics in proteomic data analysis

Drivers

  • Government support through national R&D programs and healthcare modernization initiatives
  • Growing investment by biotech and pharmaceutical companies in proteomic research
  • Rising prevalence of chronic diseases and aging population driving demand for early detection
  • Increased healthcare spending and improved infrastructure across emerging APAC economies
  • Surge in clinical trials and translational research efforts in the region

Challenges

  • High cost of proteomics instruments and data analysis platforms
  • Limited access to advanced technologies in low- and middle-income countries
  • Shortage of skilled professionals and bioinformatics expertise
  • Complex data interpretation and standardization issues
  • Regulatory and ethical concerns around patient data use and biomarker validation

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific proteomics market has been extensively segmented based on various categories, such as offering, application, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific proteomics market has numerous established players with product and service portfolios. Key players in the Asia-Pacific proteomics market analyzed and profiled in the study involve established players offering proteomics products and services.

Table of Contents

Executive Summary

Scope and Definition

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
    • 1.1.2 Proteomics Techniques by Introduction with Principles and Advantages/Limitations
  • 1.2 Key Findings
  • 1.3 Asia-Pacific Proteomics Market Scenario
    • 1.3.1 Realistic Scenario
    • 1.3.2 Optimistic Scenario
    • 1.3.3 Pessimistic Scenario
  • 1.4 Industry Outlook
    • 1.4.1 Supply Chain Overview
  • 1.5 Trends: Current and Future Impact Assessment
    • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
    • 1.5.2 Significant Number of Collaborations among Market Players
    • 1.5.3 Growing Proteomics Research to Identify Disease Biomarkers
  • 1.6 Patent Analysis
    • 1.6.1 Patent Filing Trend (by Country, Year)
  • 1.7 Regulatory Framework
    • 1.7.1 Japan
      • 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.1.2 Regulatory Requirements for Clinical Proteomics Labs in Japan
    • 1.7.2 China
      • 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
  • 1.8 Product Benchmarking
  • 1.9 Market Dynamics Overview
    • 1.9.1 Market Drivers
      • 1.9.1.1 Increasing Prevalence of Chronic Diseases
      • 1.9.1.2 Increasing Technological Advancements
      • 1.9.1.3 Advancements in Personalized Medicine and Drug Discovery
    • 1.9.2 Market Restraints
      • 1.9.2.1 Shortage of Skilled Professionals
      • 1.9.2.2 Complexity in Analyzing Data of Proteomics Research
    • 1.9.3 Market Opportunities
      • 1.9.3.1 Progress in Nanoproteomics Platforms to Enhance and Thoroughly Analyze Natural Protein Complexes

2 Proteomics Market (by Region), $Million, 2022-2034

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Asia-Pacific Proteomics Market, by Application
    • 2.2.5 Asia-Pacific Proteomics Market, by Offering
      • 2.2.5.1 Asia-Pacific Proteomics Market, by Product
    • 2.2.6 China
      • 2.2.6.1 China Proteomics Market, by Application
      • 2.2.6.2 China Proteomics Market, by Offering
        • 2.2.6.2.1 China Proteomics Market, by Product
    • 2.2.7 India
      • 2.2.7.1 India Proteomics Market, by Application
      • 2.2.7.2 India Proteomics Market, by Offering
        • 2.2.7.2.1 India Proteomics Market, by Product
    • 2.2.8 Australia
      • 2.2.8.1 Australia Proteomics Market, by Application
      • 2.2.8.2 Australia Proteomics Market, by Offering
        • 2.2.8.2.1 Australia Proteomics Market, by Product
    • 2.2.9 Japan
      • 2.2.9.1 Japan Proteomics Market, by Application
      • 2.2.9.2 Japan Proteomics Market, by Offering
        • 2.2.9.2.1 Japan Proteomics Market, by Product
    • 2.2.10 South Korea
      • 2.2.10.1 South Korea Proteomics Market, by Application
      • 2.2.10.2 South Korea Proteomics Market, by Offering
        • 2.2.10.2.1 South Korea Proteomics Market, by Product
    • 2.2.11 Rest-of-Asia-Pacific
      • 2.2.11.1 Rest-of-Asia-Pacific Proteomics Market, by Application
      • 2.2.11.2 Rest-of-Asia-Pacific Proteomics Market, by Offering
        • 2.2.11.2.1 Rest-of-Asia-Pacific Proteomics Market, by Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Proteomics Market: Competitive Landscape
    • 3.1.1 Corporate Strategies, January 2022-December 2024
  • 3.2 Company Profiles
    • 3.2.1 Takara Bio Inc.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/ Services
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Proteomics Market (by Application), $Billion, 2022, 2027, and 2034
  • Figure 2: Asia-Pacific Proteomics Market (by Product), $Billion, 2022, 2027, and 2034
  • Figure 3: Key Events to Keep Track of within the Proteomics Market
  • Figure 4: Asia-Pacific Proteomics Market Size, $Billion, 2022-2034
  • Figure 5: Proteomics Literature Published (January 2015 to December 2024)
  • Figure 6: Asia-Pacific Proteomics Market Size and Growth Potential (Realistic Scenario), $Billion, 2022-2034
  • Figure 7: Asia-Pacific Proteomics Market Size and Growth Potential (Optimistic Scenario), $Billion, 2022 to 2034
  • Figure 8: Asia-Pacific Proteomics Market Size and Growth Potential (Pessimistic Scenario), $Billion, 2022 to 2034
  • Figure 9: Supply Chain and Risks within the Supply Chain
  • Figure 10: Key Features of End-to-End Proteomics Workflow
  • Figure 11: Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
  • Figure 12: Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
  • Figure 13: Proteomics Market, Product Benchmarking (by Product)
  • Figure 14: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 15: Timeline on the Personalized Medicine Journey of Protein
  • Figure 16: Difficulties Faced in Top-Down Proteomics
  • Figure 17: Future Outlook of Nanoproteomics
  • Figure 18: Asia-Pacific Proteomics Market, $Billion, 2022-2034
  • Figure 19: Proteomics Literature Published in China (January 2015 to December 2024)
  • Figure 20: China Proteomics Market, $Billion, 2022-2034
  • Figure 21: Proteomics Literature Published in India (January 2015 to December 2024)
  • Figure 22: India Proteomics Market, $Billion, 2022-2034
  • Figure 23: Proteomics Literature Published in Australia (January 2015 to December 2024)
  • Figure 24: Australia Proteomics Market, $Billion, 2022-2034
  • Figure 25: Proteomics Literature Published in Japan (January 2015 to December 2024)
  • Figure 26: Japan Proteomics Market, $Billion, 2022-2034
  • Figure 27: Proteomics Literature Published in South Korea (January 2015 to December 2024)
  • Figure 28: South Korea Proteomics Market, $Billion, 2022-2034
  • Figure 29: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2022-2034
  • Figure 30: Corporate Strategies, January 2022-December 2024
  • Figure 31: Data Triangulation
  • Figure 32: Top-Down and Bottom-Up Approach
  • Figure 33: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: The Diversified Exposure of Proteomics
  • Table 4: Comparative Analysis of Proteomics: Advantages and Disadvantages Over Other Omics Approaches
  • Table 5: Introduction to Proteomics Techniques: Principles, Advantages, and Limitations
  • Table 6: Comparison of Existing and Emerging Paradigms in Proteomics Technologies
  • Table 7: Proteomics Market Trend Analysis
  • Table 8: Some of the Partnerships and Collaborations in the Proteomics Market
  • Table 9: List of Molecular Targets Identified with Proteomics
  • Table 10: Cancer Cases Expected Between 2020 and 2040
  • Table 11: Proteomics Market, Regulatory Approvals, and New Offerings
  • Table 12: Cancer Biomarkers Discovered by Proteomics and its Applications in Personalized Medicine
  • Table 13: Proteomics Market (by Region), $Billion, 2022-2034
  • Table 14: Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
  • Table 15: Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 16: Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034
  • Table 17: China Proteomics Market (by Application), $Billion, 2022-2034
  • Table 18: China Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 19: China Proteomics Market (by Product), $Billion, 2022-2034
  • Table 20: India Proteomics Market (by Application), $Billion, 2022-2034
  • Table 21: India Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 22: India Proteomics Market (by Product), $Billion, 2022-2034
  • Table 23: Australia Proteomics Market (by Application), $Billion, 2022-2034
  • Table 24: Australia Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 25: Australia Proteomics Market (by Product), $Billion, 2022-2034
  • Table 26: Japan Proteomics Market (by Application), $Billion, 2022-2034
  • Table 27: Japan Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 28: Japan Proteomics Market (by Product), $Billion, 2022-2034
  • Table 29: South Korea Proteomics Market (by Application), $Billion, 2022-2034
  • Table 30: South Korea Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 31: South Korea Proteomics Market (by Product), $Billion, 2022-2034
  • Table 32: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
  • Table 33: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 34: Rest-of-Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034